Xenetic Biosciences: Funding, Investors & Team (Oct 2026)
Xenetic Biosciences PLC (formerly Lipoxen PLC) Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines. Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
Xenetic Biosciences has raised $12.5M across 1 funding round on record, the most recent a Post-IPO Equity of $12.5M announced in Jul 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Xenetic Biosciences Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Xenetic Biosciences Funding Rounds
Xenetic Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Xenetic Biosciences Funding Compared to Other Biotechnology Startups
Xenetic Biosciences' latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Xenetic Biosciences in Biotechnology and Framingham
Companies Similar to Xenetic Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Xenetic Biosciences Funding FAQs
What does Xenetic Biosciences do?
Xenetic Biosciences PLC (formerly Lipoxen PLC) Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines. Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
How much funding has Xenetic Biosciences raised?
Xenetic Biosciences has raised $12.5M across 1 round on record. The most recent is a Post-IPO Equity of $12.5M announced in Jul 2021.
When did Xenetic Biosciences last raise funding?
Xenetic Biosciences' most recent funding round on record is a Post-IPO Equity of $12.5M, announced in Jul 2021.
Who is the CEO of Xenetic Biosciences?
Scott Maguire is listed as CEO at Xenetic Biosciences.
Where is Xenetic Biosciences headquartered?
Xenetic Biosciences is based in Framingham, Massachusetts, United States.
How many employees does Xenetic Biosciences have?
Xenetic Biosciences is in the 11-50 employee band.
How does Xenetic Biosciences' funding compare to other Biotechnology startups?
Xenetic Biosciences' latest round of $12.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Xenetic Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Xenetic Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.